Approval · Notice of Compliance 5692 · 1994
OPTIRAY: Notice of Compliance 5692
Issued March 11, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5692
- Date
- March 11, 1994
- Company
- Mallinckrodt MedicalAthlone, WM, Ireland
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New packaging
- Therapeutic class
- Radiopaque contrast medium for intravascular use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIRAY | Not yet assigned | — |
| OPTIRAY | 02079992 | Dormant |